Liraglutide vs Semaglutide: How the Two GLP-1 Medications Compare
Daily vs. weekly, cheaper vs. stronger—the pros and cons to help you choose.
30-Second Takeaway
- Semaglutide is more effective for weight loss and blood sugar control than liraglutide, based on numerous clinical trials.
- Injectable semaglutide is administered weekly, while liraglutide is a daily injection.
- Liraglutide often costs less than semaglutide and might result in fewer side effects.
A growing number of people are exploring GLP-1 medications for weight loss or as part of a broader effort to improve metabolic health, stabilize energy, and prevent long-term issues like diabetes or cardiovascular disease. Liraglutide (the active ingredient in Saxenda and Victoza) and semaglutide (the active ingredient in Ozempic) are two of the most studied options, and while they work through the same pathway, they differ in dosing, potency, side effects, and the kind of support they offer over time.
Both liraglutide and semaglutide mimic the GLP-1 hormone that helps control appetite, insulin, and blood sugar— helping you feel full faster and eat less. In practice, they slow digestion, reduce hunger, and improve overall metabolic health, leading to better blood-sugar control, easier weight loss, and a lower risk of diabetes and heart disease. 1 2
But how do the two drugs really compare—and which one makes the most sense for you? Choosing between them isn’t just about which one is “stronger.” It’s about understanding how your body responds, what your overall health looks like, and what you’re ultimately trying to improve—whether it’s appetite, blood sugar, weight, or healthspan.
We’ll break down the similarities and differences between liraglutide and semaglutide, from how they work and their side effects to cost, coverage, and which may be better suited to your goals.
About the expert:
Alex Watson, M.D., is a board-certified physical medicine and rehabilitation and obesity medicine physician.
What’s the Difference Between Liraglutide and Semaglutide?
While liraglutide and semaglutide work through the same GLP-1 receptor pathway, they differ in how long they act, how often they’re taken, and what they’re approved to treat.
Which Helps You Lose More Weight?
When it comes to weight loss, semaglutide has a clear edge over liraglutide. Across multiple studies, people taking semaglutide lost more body fat faster than people taking liraglutide. While some of this research was funded by Novo Nordisk (the maker of Ozempic, Wegovy, Saxenda, and Victoza), the results are clear—people on semaglutide lost nearly twice as much weight and hit the 5-percent weight-loss milestone in half the time.
Liraglutide vs. Semaglutide for Weight Loss
| Study | Duration | Average Weight Loss | Time to 5% Weight Loss |
| Liraglutide (SCALE Study) | 56 Weeks | 8% | ~5 months |
| Semaglutide (STEP Study) | 68 weeks | 15% | ~2.5 months |
“The best for obesity management strictly from a weight perspective is semaglutide,” says obesity specialist Alex Watson, M.D. “If someone just wants to lose the most weight and doesn’t have diabetes, semaglutide is the clear choice between the two medications.”
On average, it takes about two and a half months to lose 5 percent of your body weight on semaglutide versus five months on liraglutide. 3 That 5-percent drop is key because it’s the benchmark associated with meaningful improvements in blood sugar, blood pressure, and overall metabolic health.
Which is Better for Managing Diabetes?
When it comes to blood sugar control, semaglutide outperforms liraglutide. Both medications lower A1c—a measure of your average blood glucose over the past two to three months 4—but semaglutide typically produces a steeper drop.
Liraglutide vs. Semaglutide for Diabetes
| Study | Duration | A1c Improvement | Timeline |
| Liraglutide (SCALE Study) | 56 weeks | -1.3 points | 56 Weeks |
| Semaglutide (STEP Study) | 68 weeks | -1.6 points | 68 Weeks |
“If we’re going strictly by potency, semaglutide is significantly stronger at maximum doses,” Watson says.
If you have a type 2 diabetes diagnosis and solid insurance coverage, your plan will likely cover at least one branded GLP-1 medication, such as Ozempic, Victoza, or Rybelsus.
Semaglutide vs liraglutide for non-diabetics
Even for people without diabetes, improving fasting insulin and post-meal blood sugar early is one of the most powerful ways to prevent future metabolic disease.
People with prediabetes tend to see similar improvements in A1c when taking either semaglutide or liraglutide. In clinical studies, liraglutide and semaglutide both led to an average 0.3-point drop in A1c in prediabetic participants (after 56 weeks for liraglutide 5 and 68 weeks for semaglutide 6)—a small but meaningful shift for people whose blood sugar is creeping upward toward the diabetes threshold. 7 8.
For most people who don’t have an insulin deficiency, the American Diabetes Association now recommends trying a GLP-1 receptor agonist before starting insulin. 9 In these cases, the goal isn’t treating diabetes—it’s improving early glucose patterns, reducing insulin resistance, and preventing further metabolic drift. These drugs not only help lower blood sugar but also promote weight loss and may improve cardiovascular outcomes.
Do Both Drugs Protect the Heart?
While neither liraglutide nor semaglutide is FDA-approved for cardiovascular protection, research suggests both may help lower the risk of major heart-related events like heart attack, stroke, or cardiovascular death in people with type 2 diabetes.
Liraglutide vs. Semaglutide for Heart Health
| Study | Duration | Heart Health Improvement |
| Liraglutide (LEADER Trial) | 4 Years | -13% lower risk of cardiovascular events |
| Semaglutide (SUSTAIN Trial) | 2 Years | -26% lower risk of cardiovascular events |
In a study of people without diabetes, semaglutide showed about a 20 percent reduction in major cardiovascular events. 10
The primary role of GLP-1s is glucose and weight regulation, but the cardiovascular findings point to a broader impact on long-term health. For individuals with elevated risk factors—family history, rising cholesterol, high blood pressure, or increasing waist circumference—these medications may protect long-term heart health.
The working theory is that GLP-1s protect the heart through a combination of better metabolic control, lower inflammation, and direct vascular and cardiac benefits. 11 12
- GLP-1s lower blood sugar, blood pressure, body weight, and inflammation—all of which reduce strain on the heart and blood vessels 13
- GLP-1 receptors are found in the heart and arteries, where they may also improve endothelial function, increase nitric oxide, and reduce oxidative stress, helping stabilize plaque and improve how the heart uses energy, especially during stress.14
How Do I Take Liraglutide or Semaglutide?
Liraglutide and semaglutide are taken in a variety of formats and doses:
| Liraglutide | Semaglutide | |
| Available formats | Injection | Injection, oral tablets |
| Dosage schedule | Daily | Weekly |
| Half-life | 12.6 to 14.3 hours | 5.7 to 6.7 days |
| Prescription brand names | Saxenda, Victoza | Ozempic (injection), Wegovy (injection), Rybelsus (oral tablet) |
A key difference between these medications lies in how long they stay active in the body—a concept known as a drug’s half-life. The half-life is the amount of time it takes for half of the medication to be cleared from your system, or more simply, how long the drug continues to work after you take it.15 The difference in half-life explains why liraglutide must be injected daily, while semaglutide can be taken only once a week.16
Although the oral form of semaglutide has the same half-life as the injectable, it reaches its peak concentration—the highest level in your bloodstream—within one to four hours after taking it, compared to one to three days for the injectable form.
Safety and Side Effects
Like all GLP-1 medications, both liraglutide and semaglutide can cause some gastrointestinal distress including nausea, diarrhea, vomiting, reflux and constipation. The good news: Most symptoms fade as your body adjusts, usually within four to eight weeks.
More serious but less common side effects can include pancreatitis, gallbladder disease, and thyroid cancer. 17 That’s why anyone on these medications should be monitored for warning signs such as severe or persistent abdominal pain, nausea, vomiting, jaundice, or a lump or swelling in the neck. 18 19 GLP-1s also aren’t recommended for people with inflammatory bowel disease, gastroparesis, or a family history of thyroid cancer.
Hone clinicians see that daily injections tend to be harder to stick with, which often matters more for results than the drug’s theoretical potency. “When deciding which of these GLP-1 receptor agonist medications is best for a patient, we discuss other factors like whether they’ll struggle with daily injections (favoring semaglutide) or are prone to gastrointestinal symptoms (favoring liraglutide),” Watson says.
He adds that for people who occasionally need to take a break from the medication—say, when side effects make social or work events awkward—liraglutide can be the better option because you can skip individual days as needed.
Cost and Insurance Coverage
Out-of-pocket prices vary by drug, dose, and insurance, ranging from $349 to $1,600-plus per month.
Semaglutide (self-pay offers via NovoCare Pharmacy)
- Ozempic (weekly injection):
- $199/month for the first 2 fills at 0.25 mg or 0.5 mg,
- Then $349/month for 0.25/0.5/1 mg; $499/month for 2 mg. 20
- Wegovy (weekly injection):
- $199/month for the first 2 fills at 0.25 mg or 0.5 mg
- Then $349/month for all doses thereafter. 21
- Rybelsus (oral):
- No fixed self-pay list price posted
- Savings program for commercially insured patients can lower cost (e.g., as little as $10/month for 3 mg). 22
Liraglutide
- Saxenda (daily injection):
- Ranges from $1,349 to $1600 per month for a 3 mg dose, though manufacturer pages emphasize savings tools and insurance checks.
- Discount coupons can bring the price down to $372.45 per month. 23
- Victoza (daily injection):
- $800 to $1,400 per month; depending on coverage and pharmacy.
- Discount coupons can bring the price down to $232 per month. 24
Hone Health offers compounded liraglutide for $165 per month with a $149 monthly membership fee.
With insurance, coverage varies depending on the reason for your prescription. Plans are more likely to cover GLP-1s when they’re prescribed for type 2 diabetes than when they’re used for weight loss. Medications such as Ozempic, Rybelsus, and Victoza typically have better coverage than Wegovy or Saxenda.
Even with insurance, many patients face hurdles like prior authorizations or step therapy. Some self-pay offers are time-bound promos with eligibility limits (e.g., two introductory fills, 28-day “month,” commercial insurance exclusions for certain offers), so always review the fine print before relying on a quoted price. And check your plan carefully before filling the prescription so you know what you’re getting into.25
Liraglutide Isn’t Working—Should I Switch to Semaglutide?
If liraglutide isn’t helping you lose weight, you have options, including changing your dose or timing or switching from liraglutide to semaglutide.
Watson typically starts patients on liraglutide, which tends to be the gentlest and least expensive of the GLP-1s; then reassesses as needed. Semaglutide and newer GLP-1s are more powerful but come with a higher chance of side effects and a steeper price tag.
“If someone experiences incomplete benefits while titrating up liraglutide doses, we may switch to semaglutide after reaching the maximum dose,” says Watson. “This stepwise approach can be the most cost-effective strategy.”
Switching from semaglutide to liraglutide is also an option, particularly when side effects are impacting the patient’s overall health. “If someone can’t tolerate or afford semaglutide, we may move them back to liraglutide,” Watson explains. “And if a patient meets their goals—loses weight, improves blood sugar, blood pressure, or cholesterol—we may even de-escalate therapy by lowering the semaglutide dose or switching to liraglutide to prevent excess weight loss, which can come at the expense of muscle mass.”
Overall, switching works best when it’s intentional and coordinated with your physician. “It’s better to switch as infrequently as possible to avoid confusion around dosing differences between formulas,” Watson says.
Alternatives to Liraglutide and Semaglutide
If liraglutide or semaglutide isn’t working for you, consider other GLP-1 medications, next-generation combination drugs, and lifestyle-based approaches.
GLP-1s
Two major GLP-1 alternatives are:
- dulaglutide (Trulicity)
- tirzepatide (Mounjaro, Zepbound)
Trulicity and Mounjaro are both FDA-approved to manage type 2 diabetes by improving blood sugar; Zepbound is approved for chronic weight management and a sleep disorder called obstructive sleep apnea. 26 27 28
In a trial that examined the effects of tirzepetide once-weekly injection for obesity, people lost between 15 and 21 percent of their body weight—similar to or even better than semaglutide. 29 By contrast, in a study of Liraglutide for weight reduction (in people with type 2 diabetes) participants lost about 6 percent of their body weight, depending on dose. 30
Weight-loss injections
Some clinics offer fat-dissolving or lipotropic injections, marketed as nonsurgical or “natural” weight-loss treatments that aren’t GLP-1 medications. These injections are not FDA-approved for weight loss and can cause side effects such as infection, scarring, and uneven skin texture. The FDA recommends talking with your healthcare provider before considering them. 31
Lifestyle measures
If you’re looking for natural alternatives to GLP-1s, diet and exercise remain two of the most effective, accessible ways to lose weight and prevent chronic disease. Small, consistent improvements—more nutrient-dense foods, regular movement, better sleep—can make a measurable difference. 32
FAQs
Is liraglutide just the older version of semaglutide?
Think of semaglutide as a next-generation GLP-1—it works the same way in the body as liraglutide, but its molecular design makes it longer-lasting and more potent. Structural changes help it bind more tightly to the GLP-1 receptor and resist breakdown, allowing once-weekly dosing instead of daily injections.
Liraglutide (Victoza) was approved in 2010, followed by Saxenda (for weight loss) in 2014.33 Semaglutide (Ozempic) was approved in 2017, Wegovy (for weight loss) in 2021, and Rybelsus (oral) shortly thereafter.
Is liraglutide safer than semaglutide?
Liraglutide and semaglutide are both safe GLP-1 medications but Liraglutide is generally easier on the stomach, while semaglutide is more potent and slightly more likely to cause side effects.
Because liraglutide is shorter-acting and taken daily, side effects like nausea or vomiting tend to be milder and easier to manage. Semaglutide, taken weekly, offers greater weight loss and blood-sugar improvement but can trigger stronger GI symptoms during dose escalation.
A 2025 real-world safety comparison found the two drugs had “distinct safety profiles,” rather than one being safer overall. 36 Current evidence suggests a possible link to depressive or suicidal ideation specific to semaglutide 37, and a clearly higher incidence of gastrointestinal adverse events compared with liraglutide.38
Both remain FDA-approved and well-studied. The best choice often comes down to individual tolerance, treatment goals, and cost.
Is liraglutide or semaglutide safe when compounded?
Compounded formulas are essentially copies of an original drug created by a specialty pharmacy. While compounding pharmacies must adhere to strict guidelines, their manufacturing process is more prone to errors like incorrect units of measurement, inappropriate vial or syringe sizes, and other issues.
What happens when you stop taking liraglutide or semaglutide?
Studies show that when people quit GLP-1 medications after a year, they tend to regain up to two-thirds of the weight they lost. To make the results stick, doctors recommend pairing medication with consistent lifestyle changes—regular physical activity, nutritional support, and community or coaching programs.
Can I take liraglutide and semaglutide at the same time?
No, you should not take liraglutide and semaglutide together. Both are GLP-1 receptor agonists that work the same way in the body. Combining them won’t improve results and could increase side effects like nausea, vomiting, diarrhea, or, in rare cases, pancreatitis. Their prescribing information specifically warns against using two GLP-1s at once. If one isn’t working, your doctor can transition you from one to the other with proper timing to avoid overlap and minimize side effects.
Why am I not losing weight?
GLP-1 medications have changed the game for weight loss, but not everyone sees the same results. Some people lose weight quickly, while others stall or plateau. While that can happen with liraglutide and semaglutide, it’s more common with liraglutide.
These key factors can slow progress:
- metabolism—how fast your body burns calories at rest
- whether you dose as directed or skip doses
- lack of consistent lifestyle changes like diet and exercise
- stopping because of side effects
- age
- having a lower starting weight, BMI, or waist circumference
The Bottom Line
Both liraglutide and semaglutide help control blood sugar, support weight loss, and lower cardiovascular risk. The main differences come down to potency, dosing, and tolerability. Liraglutide is taken daily, tends to be easier on the stomach, and costs less; semaglutide is taken weekly, produces greater results, but is pricier and more likely to cause GI side effects.
Logan Collins, et al. (2024) Glucagon-like peptide-1 receptor agonists
↑Levi Hooper, et al. (2025) GLP-1RA-induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis
↑Wissam Ghusn, et al. (2022) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity
↑Life with diabetes. Health checks for people with diabetes. (n.d.)
↑Pi-Sunyer, Xavier, et al (2015) A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
↑Campbell, Sydney et al. (2021) Glutamine deprivation triggers NAGK-dependent hexosamine salvage
↑Anthony A. Bavry, et al. (2017) Obesity and prediabetes trial – SCALE
↑Leigh Perreault, et al. (2022) Changes in glucose metabolism and glycemic status with once-weekly subcutaneous semaglutide 2.4 mg among participants with prediabetes in the STEP program
↑American Diabetes Association Professional Practice Committee. (2022) 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2022
↑A. Michael Lincoff, et al. (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes
↑Ussher, John R., Drucker, Daniel J. (2023) Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
↑Muller, Neerav et al. (2021) GLP-1 receptor agonist-based and cardiovascular risk: a review of mechanisms
↑Muller, Neerav et al. (2021) GLP-1 receptor agonist-based and cardiovascular risk: a review of mechanisms
↑Ussher, John R., Drucker, Daniel J. (2023) Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
↑Jericho Hallare, et al. (2025) Elimination half-life of drugs
↑Wafa Latif, et al. (2024) Compare and contrast the glucagon-like peptide-1 receptor agonists
↑Wafa Latif, et al. (2024) Compare and contrast the glucagon-like peptide-1 receptor agonists
↑FDA (2023) Prescribing Information, Saxenda
↑FDA (2023) Prescribing Information, Ozempic
↑Novo Nordisk (2025) Ozempic® Savings Offer
↑Novo Nordisk (2025) Wegovy® Supply Update
↑Novo Nordisk (2025) Rybelsus® Savings & Support
↑Novo Nordisk (2025) Saxenda® Savings Program
↑Novo Nordisk (2025) Victoza® Coverage & Reimbursement FAQs
↑Novo Nordisk. NovoCare® Patient Support & Savings
↑TRULICITY- dulaglutide injection, solution (2025)
↑What is Mounjaro? (2025)
↑Zepbound (Tirzepatide) injection (2025)
↑Ania M. Jastreboff, et al. (2022) Tirzepatide once weekly for the treatment of obesity
↑Juan P. Frias, et al. (2021) Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 Diabetes in a randomized controlled trial (AWARD-11)
↑Using fat-dissolving injections that are not FDA approved can be harmful (2023)
↑Sareen S. Gropper. (2023) The role of nutrition in chronic disease
↑
Mentioned in This Article:
Compounded Liraglutide
Compounded liraglutide is a daily injection that helps support weight loss by mimicking the GLP-1 hormone, which regulates blood sugar, reduces appetite, and promotes lasting fullness after meals.
Editorial Policy: Science-Backed, Expert-Reviewed
The Edge upholds the highest standards of health journalism. We source research from peer-reviewed medical journals, top government agencies, leading academic institutions, and respected advocacy groups. We also go beyond the research, interviewing top experts in their fields to bring you the most informed insights. Every article is rigorously reviewed by medical experts to ensure accuracy. Contact us at support@honehealth.com if you see an error.
About the author
Britt Gambino is a New York City area editor, writer, and teacher with 20 years of media and education experience. As a senior editor for Healthline Media, Britt worked to bring dozens of health content marketing programs to life. She pitched and developed content tailored to audiences at various points in their health journey. She also partnered with nonprofit organizations such as (RED), the American Lung Association, and Multiple Sclerosis (MS) Association of America, among others, to further their missions and raise awareness through co-created content.
About the reviewer
Carol Lynn, MD is a board-certified OB/GYN who specializes in menopause management. She is a member of the American Board of OB/GYN (ABOG) and the North American Menopause Society (NAMS).
